HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration

Neurology. 2002 Jun 11;58(11):1673-4. doi: 10.1212/wnl.58.11.1673.

Abstract

HARP (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration) is a rare syndrome with many clinical similarities to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). Despite these common features, lipoprotein abnormalities have not been reported in PKAN. After the recent discovery of the genetic defect in PKAN, we report a homozygous nonsense mutation in exon 5 of the PANK2 gene that creates a stop codon at amino acid 371 (R371X) in the original HARP patient. This finding establishes that HARP is part of the PKAN disease spectrum.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acanthocytes / enzymology
  • Alleles
  • Codon, Nonsense
  • Globus Pallidus / pathology
  • Humans
  • Hypobetalipoproteinemias / genetics*
  • Neurodegenerative Diseases / genetics*
  • Neurodegenerative Diseases / pathology
  • Pantothenate Kinase-Associated Neurodegeneration / genetics*
  • Phosphotransferases (Alcohol Group Acceptor) / genetics*
  • Retinitis Pigmentosa / genetics*

Substances

  • Codon, Nonsense
  • Phosphotransferases (Alcohol Group Acceptor)
  • pantothenate kinase